Innovative approaches in the treatment and support of patients with acute myelogenous leukemia.
Rowe
Jacob M
JM
Department of Hematology and BMT, Rambam Medical Center and Technion, Israel Institute of Technology, Haifa 31096, Israel. rowe@jimmy.harvard.edu
D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D033581:Stem Cell Transplantation; D016896:Treatment Outcome
D000970:Antineoplastic Agents